[Challenges and future perspectives in neuro-oncology].

Herausforderungen und Zukunftsperspektiven in der Neuroonkologie.
Central nervous system Metastases Neurologic complications Primary tumors Transition medicine

Journal

Der Nervenarzt
ISSN: 1433-0407
Titre abrégé: Nervenarzt
Pays: Germany
ID NLM: 0400773

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 11 5 2019
medline: 3 9 2019
entrez: 11 5 2019
Statut: ppublish

Résumé

Neuro-oncology is a young and emerging discipline. An interdisciplinary mindset and concerted actions in specialized expert teams are required to meet the challenges, not only in clinical patient care but also in research activities. A close communication network between clinician scientists, medical scientists and data scientists is required to ensure that emerging data from basic, translational and clinical research can be used for improving the sometimes extremely limited and prognostically unsatisfactory treatment options. The continuously developing spectrum of tasks in neuro-oncology includes the classical fields of primary and metastatic tumors of the central nervous system and neurological complications from cancer therapies. It also includes challenges of transition of patients with a disease onset in childhood from pediatric to adult neuro-oncology. This is particularly relevant because the treatment options and the prognosis of primary brain tumors in childhood have improved tremendously. Thus, a close cooperation between pediatric and adult neuro-oncology is necessary to ensure a seamless transition. All these considerations lead to specific challenges for specialized centers of excellence to ensure an innovative, competitive and sustainable framework for modern neuro-oncology.

Identifiants

pubmed: 31073670
doi: 10.1007/s00115-019-0716-4
pii: 10.1007/s00115-019-0716-4
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

594-600

Références

N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Clin Oncol. 2010 Apr 10;28(11):1963-72
pubmed: 20231676
J Neurooncol. 2012 Apr;107(2):359-64
pubmed: 22045118
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Brain Pathol. 2017 Nov;27(6):851-852
pubmed: 27997995
Neuro Oncol. 2017 Feb 1;19(2):162-174
pubmed: 28391295
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
N Engl J Med. 2017 Jul 6;377(1):62-70
pubmed: 28679092
Ann Oncol. 2017 Jul 1;28(suppl_4):iv84-iv99
pubmed: 28881917
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
Acta Neuropathol. 2019 Apr;137(4):683-687
pubmed: 30848347
J Clin Oncol. 2019 May 1;37(13):1047-1050
pubmed: 30897036
Nervenarzt. 2019 Jun;90(6):587-593
pubmed: 31089783

Auteurs

Ghazaleh Tabatabai (G)

Interdisziplinäre Sektion Neuro-Onkologie, Abteilung Neurologie mit Schwerpunkt neurovaskuläre Erkrankungen und Neuroonkologie & Klinik für Neurochirurgie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neuroonkologie des Comprehensive Cancer Center Tübingen-Stuttgart, Universitätsklinik Tübingen, Eberhard Karls Universität Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland. ghazaleh.tabatabai@uni-tuebingen.de.

Michael Weller (M)

Neurologische Klinik, Hirntumorzentrum, UniversitätsSpital Zürich, Universität Zürich, Zürich, Schweiz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH